Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Lilly’s Olaratumab (Lartruvo) to treat sarcoma

europeanpharmaceuticalreviewJune 15, 2017

Tag: NICE , Olaratumab

PharmaSources Customer Service